Hilary Eaton

R&D

Hilary Eaton, a rare disease advocate and chief business officer at Profluent, discusses AI-first protein design and accelerating biomedicine.

News

UK Health Secretary Wes Streeting has resigned from Keir Starmer's government, saying he has lost faith in the Prime Minister's leadership.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.